Výsledky vyhledávání - Angela Gradilone
- Zobrazuji výsledky 1 - 9 z 9
-
1
-
2
PD-L1 and epithelial-mesenchymal transition in circulating tumor cells from non-small cell lung cancer patients: A molecular shield to evade immune system<b>?</b> Autor Cristina Raimondi, Guido Carpino, Chiara Nicolazzo, Angela Gradilone, Walter Gianni, Alain Gelibter, Eugenio Gaudio, Enrico Cortesi, Paola Gazzaniga
Vydáno 2017Artigo -
3
Expression and prognostic significance of LIVIN, SURVIVINand other apoptosis-related genes in the progression of superficial bladder cancer Autor Paola Gazzaniga, Angela Gradilone, Laura Giuliani, Orietta Gandini, Ida Silvestri, Italo Nofroni, Gloria Saccani, L. Frati, Anna Maria Aglianò
Vydáno 2002Artigo -
4
Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer Autor Cristina Raimondi, Chiara Nicolazzo, Francesca Belardinilli, Flavia Loreni, Angela Gradilone, Yasaman Mahdavian, Alain Gelibter, Giuseppe Giannini, Enrico Cortesi, Paola Gazzaniga
Vydáno 2019Artigo -
5
Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal Autor Angela Gradilone, Cristina Raimondi, Chiara Nicolazzo, Arianna Petracca, Orietta Gandini, Bruno Vincenzi, Giuseppe Naso, Anna Maria Aglianò, Enrico Cortesi, Paola Gazzaniga
Vydáno 2011Artigo -
6
bcl-2/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer Autor Paola Gazzaniga, Angela Gradilone, Roberta Vercillo, Orietta Gandini, Ida Silvestri, Maria Napolitano, Loredana Albonici, Vincenzoni Andrea, Michele Gallucci, L. Frati, Anna-Maria Aglianó
Vydáno 1996Artigo -
7
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial Autor Chiara Nicolazzo, Gian Maria Busetto, Angela Gradilone, Isabella Sperduti, Francesco Del Giudice, Flavia Loreni, Enrico Cortesi, Ettore De Berardinis, Paola Gazzaniga, Cristina Raimondi
Vydáno 2019Artigo -
8
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab Autor Chiara Nicolazzo, Cristina Raimondi, M. Mancini, S Caponnetto, Angela Gradilone, Orietta Gandini, Maria Mastromartino, Gabriella Del Bene, Alessandra Anna Prete, Flavia Longo, Enrico Cortesi, Paola Gazzaniga
Vydáno 2016Artigo -
9
Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization Autor Angela Gradilone, Giuseppe Naso, Cristina Raimondi, Enrico Cortesi, Orietta Gandini, Bruno Vincenzi, Rosa Saltarelli, E. Chiapparino, Franco Spremberg, Massimo Cristofanilli, Luigi Frati, Anna Maria Aglianò, Paola Gazzaniga
Vydáno 2010Artigo
Vyhledávací nástroje:
Související témata
Cancer
Internal medicine
Medicine
Oncology
Cancer research
Circulating tumor cell
Metastasis
Biology
Genetics
Bladder cancer
Gene
Immunology
Pathology
Apoptosis
Breast cancer
Cancer stem cell
Cell
Chemotherapy
Colorectal cancer
Epithelial–mesenchymal transition
Gene expression
Immunotherapy
Lung cancer
Metastatic breast cancer
Nivolumab
PD-L1
Predictive marker
Programmed cell death
Survivin
Antibody